SelectQuote reports Q1 FY2023 revenue $162.5M, net loss $42.5M; reaffirms guidance

SelectQuote, Inc.

2023-Q1 EPS reported -$0.26 revenue$162,484,000

Revenue of $162.5M vs $156.1M YoY; net loss narrowed to $42.5M from $48.2M YoY.
Adjusted EBITDA of $(27.5)M, improved from $(47.9)M YoY; Senior Adjusted EBITDA $(3.9)M.
Senior segment revenue $77.5M (down 23% YoY); Healthcare Services revenue surged 620% to $43.1M.
Reaffirms FY2023 guidance: revenue $850-$950M, net loss $113M to $89M, Adj. EBITDA $(20)M to $10M.
SelectRx members grew to 32,596 from 5,006 YoY; CEO cites strong start ahead of Medicare AEP.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SelectQuote, Inc. reported first quarter ended September 30, 2022 results: revenue $162.5 million, net income $42.5 million. Guidance reaffirmed.

Period: first quarter ended September 30, 2022
Revenue: $162.5 million
Net income: $42.5 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

such filing. --- EX-99.1 (EX-99.1) --- SelectQuote, Inc. Reports First Quarter 2023 Results First Quarter of Fiscal Year 2023 – Consolidated Earnings Highlights • Revenue of $162.5 million • Net loss of $42.5 million • Adjusted EBITDA* of $(27.5) million Reaffirming Fiscal Year 2023 Guidance Ranges: • Revenue expected in a range of $850 million to $950 million •

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

SelectQuote, Inc. filing history →

Source: SEC EDGAR

accession 0001794783-22-000087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.